Aquestive Therapeutics, Inc. — Director's Dealing 2018

Jul 26, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-07-24

Reporting Person: Monoline Partners, L.P. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	165000	Direct

Footnotes

F1: MonoLine Partners, L.P., beneficially owns less than 10% of the outstanding securities of the Issuer, but, pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), it may be deemed to be a more than 10% beneficial owner of such stock because it may be deemed to be a member of a "group" that owns in excess of 10% of such outstanding stock pursuant to Section 13(d)(3) under the Act. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that either of the Reporting Persons is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any equity securities of the Issuer owned by any other person.